Self-assembled nanoparticles based on glycol chitosan bearing 5beta-cholanic acid for RGD peptide delivery.
暂无分享,去创建一个
Ick Chan Kwon | Seo Young Jeong | In-San Kim | Jae Hyung Park | I. Kwon | In‐San Kim | J. Park | Hesson Chung | S. Jeong | R. Park | Ju-Ock Nam | Seunglee Kwon | Rang-Woon Park | Seunglee Kwon | Ju-Ock Nam | Hesson Chung | Sang Bong Seo | S. Seo
[1] I. Kwon,et al. Structural characteristics of size-controlled self-aggregates of deoxycholic acid-modified chitosan and their application as a DNA delivery carrier. , 2001, Bioconjugate chemistry.
[2] S. Groshen,et al. Integrins αvβ3 and αvβ5 Are Expressed by Endothelium of High-Risk Neuroblastoma and Their Inhibition Is Associated with Increased Endogenous Ceramide , 2000 .
[3] D. Cheresh,et al. Requirement of vascular integrin alpha v beta 3 for angiogenesis. , 1994, Science.
[4] I. Kwon,et al. Synthesis and Micellar Characterization of Amphiphilic Diblock Copolymers Based on Poly(2-ethyl-2-oxazoline) and Aliphatic Polyesters1 , 1999 .
[5] I. Kwon,et al. Biodistribution and anti-tumor efficacy of doxorubicin loaded glycol-chitosan nanoaggregates by EPR effect. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[6] I. Kwon,et al. Synthesis and characterization of sugar-bearing chitosan derivatives: aqueous solubility and biodegradability. , 2003, Biomacromolecules.
[7] Kinam Park,et al. Controlled drug delivery : designing technologies for the future , 2000 .
[8] J. Park,et al. Identification of the αvβ3 Integrin-interacting Motif of βig-h3 and Its Anti-angiogenic Effect* , 2003, Journal of Biological Chemistry.
[9] T. Okano,et al. Development of the polymer micelle carrier system for doxorubicin. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[10] D. Cheresh,et al. Synergy between an antiangiogenic integrin alphav antagonist and an antibody-cytokine fusion protein eradicates spontaneous tumor metastases. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[11] V. Torchilin,et al. Biodegradable long-circulating polymeric nanospheres. , 1994, Science.
[12] H. Hammes,et al. Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor–type integrins inhibits retinal neovascularization , 1996, Nature Medicine.
[13] E. Ruoslahti. Specialization of tumour vasculature , 2002, Nature Reviews Cancer.
[14] Eun Seong Lee,et al. Adriamycin loaded pullulan acetate/sulfonamide conjugate nanoparticles responding to tumor pH: pH-dependent cell interaction, internalization and cytotoxicity in vitro. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[15] K. Akiyoshi,et al. Macromolecular Complexation between Bovine Serum Albumin and the Self-Assembled Hydrogel Nanoparticle of Hydrophobized Polysaccharides , 1996 .
[16] S Ferrone,et al. Expression of the high molecular weight melanoma-associated antigen by pericytes during angiogenesis in tumors and in healing wounds. , 1989, The American journal of pathology.
[17] J. Park,et al. Identification of Motifs in the Fasciclin Domains of the Transforming Growth Factor-β-induced Matrix Protein βig-h3 That Interact with the αvβ5 Integrin* , 2002, The Journal of Biological Chemistry.
[18] David A. Cheresh,et al. Definition of Two Angiogenic Pathways by Distinct αv Integrins , 1995, Science.
[19] Y. Bae,et al. Self-assembled hydrogel nanoparticles from curdlan derivatives: characterization, anti-cancer drug release and interaction with a hepatoma cell line (HepG2). , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[20] I. Kwon,et al. Synthesis of Triarmed Poly(ethylene oxide)−Deoxycholic Acid Conjugate and Its Micellar Characteristics , 2000 .
[21] G. Kwon,et al. Micelles self-assembled from poly(ethylene oxide)-block-poly(N-hexyl stearate L-aspartamide) by a solvent evaporation method: effect on the solubilization and haemolytic activity of amphotericin B. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[22] E. Ruoslahti,et al. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. , 1998, Science.
[23] P. Carmeliet,et al. Angiogenesis in cancer and other diseases , 2000, Nature.
[24] D. Cheresh,et al. Integrin α v β 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels , 1994, Cell.
[25] D. Cheresh,et al. The role of alphav integrins during angiogenesis: insights into potential mechanisms of action and clinical development. , 1999, The Journal of clinical investigation.
[26] Ick Chan Kwon,et al. Porous chitosan scaffold containing microspheres loaded with transforming growth factor-beta1: implications for cartilage tissue engineering. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[27] John Samuel,et al. Poly(ethylene oxide)-block-poly(L-amino acid) micelles for drug delivery. , 2002, Advanced drug delivery reviews.
[28] Ick Chan Kwon,et al. Physicochemical Characteristics of Self-Assembled Nanoparticles Based on Glycol Chitosan Bearing 5β-Cholanic Acid , 2003 .
[29] I. Kwon,et al. Preparation of chitosan self-aggregates as a gene delivery system. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[30] R Pasqualini,et al. NG2 proteoglycan-binding peptides target tumor neovasculature. , 1999, Cancer research.
[31] Teruo Okano,et al. Block copolymer micelles for drug delivery: Loading and release of doxorubicin , 1997 .
[32] S. Hirano. Chitin and chitosan as novel biotechnological materials , 1999 .
[33] Teruo Okano,et al. Physical Entrapment of Adriamycin in AB Block Copolymer Micelles , 1995, Pharmaceutical Research.
[34] In‐San Kim,et al. A TGF‐β‐inducible cell adhesion molecule, βig‐h3, is downregulated in melorheostosis and involved in osteogenesis , 2000 .
[35] Grietje Molema,et al. Drug Targeting: Organ-Specific Strategies , 2001 .